Anti-TNF Therapy After 24 Weeks of Pregnancy Appears Safe: Study
Continuing anti-TNF therapy after 24 weeks of pregnancy is associated with a lower likelihood of relapse of IBD in pregnant women and fewer premature deliveries, according to a new report.
Source: medscape.com